4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-055471
Chairman and CEO bought 27,500 shares at an average $0.44 ($11,975)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-10-31 | Purchase | +7,500 | $0.45 | $3,375 | 11,968,257 | D |
| Niihara Yutaka Chairman and CEO | 2022-11-01 | Purchase | +5,000 | $0.43 | $2,150 | 11,973,257 | D |
| Niihara Yutaka Chairman and CEO | 2022-11-02 | Purchase | +15,000 | $0.43 | $6,450 | 11,988,257 | D |
| Open-market purchases · 27,500 sh · avg $0.44 · $11,975 | |||||||
Loading xslF345X03/doc4.xml…